PAX5 and acute lymphoblastic leukemia: The two distinct disease-initiating alterations of PAX5 that result in PAX5alt and PAX5 p.Pro80Arg ALL account for approximately 3% to 5% and less than 1% of childhood ALL, respectively [9,10].